Denali Therapeutics Inc.
161 Oyster Point Boulevard
South San Francisco
132 articles about Denali Therapeutics Inc.
Denali plans to make a $100M IPO under the symbol DNLI.
What You Need to Know About Denali
BioSpace is proud to present its NextGen “Class of 2017,” which is a list of 20 up-and-coming life science companies that launched no earlier than 2014.
Led by Former Genentech Execs, Denali Banks $130 Million, Initiates Trial and Announces a Handful of Partnerships
f-Star Announces Collaborative Agreement With Denali For The Development Of A Multispecific Antibody Platform To Deliver Therapeutics Across The Blood-Brain Barrier
Nine Bay Area Biotechs Vie to be the “Next Genentech”
Inside the $50 Billion Biotech Sugar Daddy that Invested in Startups Like Denali, Juno
Denali, Helmed by Former Genentech Execs, Takes Space in South San Francisco Site
Denali Appoints Steve E. Krognes As Chief Financial Officer
Denali Appoints Carole Ho, M.D., As Chief Medical Officer And Head Of Development
Pfizer Board Member Jumps Ship to $217 Million Startup Denali
Why Denali Raised A $217 Million Financing Round: Not Just "Because It Could"